At Prenosis, I coordinate, execute, and monitor government-sponsored observational and interventional studies across research institutions in the United States. I verify source documents and record study data in line with regulatory requirements.
At Q Laboratories, I coordinated medical device project timelines and deliverables under FDA, U.S., and EU regulations. I also led a cross-functional team whose work generated over $1.9 million in revenue across more than 210 medical device projects.
At Louisiana State University Health Sciences Center, I monitored antibiotic effects on Chlamydia trachomatis infections in vitro and confirmed and removed mycoplasma from cell cultures. This work was also reflected in my publication on a curative approach to mycoplasma decontamination in Chlamydia trachomatis culture.
